Clinical Applications for Biomarkers of Acute and Chronic Graft-versus-Host Disease

John E. Levine, Sophie Paczesny, Stefanie Sarantopoulos

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Acute and chronic graft-versus-host disease (aGVHD, cGVHD) are serious complications of allogeneic hematopoietic cell transplantation. The complex pathophysiology of these disease processes is associated with immune system activation, the release of cytokines and chemokines, and alterations in cell populations. The blood levels of specific protein and cellular levels in patients with GVHD have correlated with the development, diagnosis, and prognosis of GVHD. Here, we review the most promising biomarkers for aGVHD and cGVHD with clinical relevance. The utility of GVHD biomarkers in clinical care of allogeneic hematopoietic cell transplantation recipients needs to be proven through clinical trials, and potential approaches to trial design are discussed.

Original languageEnglish (US)
JournalBiology of Blood and Marrow Transplantation
Volume18
Issue number1 SUPPL.
DOIs
StatePublished - Jan 2012
Externally publishedYes

Fingerprint

Cell Transplantation
Graft vs Host Disease
Biomarkers
Chemokines
Immune System
Clinical Trials
Cytokines
Population
Proteins

Keywords

  • Acute GVHD
  • Allogeneic hematopoietic cell transplantation
  • Biomarkers
  • Chronic GVHD

ASJC Scopus subject areas

  • Transplantation
  • Hematology

Cite this

Clinical Applications for Biomarkers of Acute and Chronic Graft-versus-Host Disease. / Levine, John E.; Paczesny, Sophie; Sarantopoulos, Stefanie.

In: Biology of Blood and Marrow Transplantation, Vol. 18, No. 1 SUPPL., 01.2012.

Research output: Contribution to journalArticle

@article{2896fb3ac7814f76bed28ea9c149219e,
title = "Clinical Applications for Biomarkers of Acute and Chronic Graft-versus-Host Disease",
abstract = "Acute and chronic graft-versus-host disease (aGVHD, cGVHD) are serious complications of allogeneic hematopoietic cell transplantation. The complex pathophysiology of these disease processes is associated with immune system activation, the release of cytokines and chemokines, and alterations in cell populations. The blood levels of specific protein and cellular levels in patients with GVHD have correlated with the development, diagnosis, and prognosis of GVHD. Here, we review the most promising biomarkers for aGVHD and cGVHD with clinical relevance. The utility of GVHD biomarkers in clinical care of allogeneic hematopoietic cell transplantation recipients needs to be proven through clinical trials, and potential approaches to trial design are discussed.",
keywords = "Acute GVHD, Allogeneic hematopoietic cell transplantation, Biomarkers, Chronic GVHD",
author = "Levine, {John E.} and Sophie Paczesny and Stefanie Sarantopoulos",
year = "2012",
month = "1",
doi = "10.1016/j.bbmt.2011.10.019",
language = "English (US)",
volume = "18",
journal = "Biology of Blood and Marrow Transplantation",
issn = "1083-8791",
publisher = "Elsevier Inc.",
number = "1 SUPPL.",

}

TY - JOUR

T1 - Clinical Applications for Biomarkers of Acute and Chronic Graft-versus-Host Disease

AU - Levine, John E.

AU - Paczesny, Sophie

AU - Sarantopoulos, Stefanie

PY - 2012/1

Y1 - 2012/1

N2 - Acute and chronic graft-versus-host disease (aGVHD, cGVHD) are serious complications of allogeneic hematopoietic cell transplantation. The complex pathophysiology of these disease processes is associated with immune system activation, the release of cytokines and chemokines, and alterations in cell populations. The blood levels of specific protein and cellular levels in patients with GVHD have correlated with the development, diagnosis, and prognosis of GVHD. Here, we review the most promising biomarkers for aGVHD and cGVHD with clinical relevance. The utility of GVHD biomarkers in clinical care of allogeneic hematopoietic cell transplantation recipients needs to be proven through clinical trials, and potential approaches to trial design are discussed.

AB - Acute and chronic graft-versus-host disease (aGVHD, cGVHD) are serious complications of allogeneic hematopoietic cell transplantation. The complex pathophysiology of these disease processes is associated with immune system activation, the release of cytokines and chemokines, and alterations in cell populations. The blood levels of specific protein and cellular levels in patients with GVHD have correlated with the development, diagnosis, and prognosis of GVHD. Here, we review the most promising biomarkers for aGVHD and cGVHD with clinical relevance. The utility of GVHD biomarkers in clinical care of allogeneic hematopoietic cell transplantation recipients needs to be proven through clinical trials, and potential approaches to trial design are discussed.

KW - Acute GVHD

KW - Allogeneic hematopoietic cell transplantation

KW - Biomarkers

KW - Chronic GVHD

UR - http://www.scopus.com/inward/record.url?scp=84855376470&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855376470&partnerID=8YFLogxK

U2 - 10.1016/j.bbmt.2011.10.019

DO - 10.1016/j.bbmt.2011.10.019

M3 - Article

C2 - 22226094

AN - SCOPUS:84855376470

VL - 18

JO - Biology of Blood and Marrow Transplantation

JF - Biology of Blood and Marrow Transplantation

SN - 1083-8791

IS - 1 SUPPL.

ER -